

Can't find Tenofovir Alafenamide (Vemlidy) at your pharmacy? Here are proven tools and tips to locate this hepatitis B medication in stock near you.
You hand over your prescription for Tenofovir Alafenamide, and the pharmacist gives you the news: "We don't have it in stock." For patients managing chronic hepatitis B, hearing this can be stressful. Missing doses of your antiviral medication isn't just inconvenient — it can lead to a dangerous flare-up of the virus.
The good news? There are practical steps you can take right now to find Tenofovir Alafenamide (brand name Vemlidy) in stock near you. In this guide, we'll walk you through the best tools and strategies.
Before we get into solutions, it helps to understand the problem. Vemlidy is a brand-name specialty medication that costs around $1,500 to $1,800 per month without insurance. Many pharmacies — especially large chains — don't stock it routinely because it serves a smaller patient population. There's also no US-marketed generic as of 2026, which limits availability further.
For a deeper look at the reasons behind these challenges, see our post on why Tenofovir Alafenamide is so hard to find.
The fastest way to find Tenofovir Alafenamide in stock is to use Medfinder. Instead of calling pharmacy after pharmacy and waiting on hold, Medfinder lets you search for pharmacies near you that currently have your medication available.
Here's how it works:
This can save you hours of phone calls and the stress of driving to multiple pharmacies only to find empty shelves. For more details, check out our guide on how to check if a pharmacy has Tenofovir Alafenamide in stock.
If your usual chain pharmacy doesn't carry Vemlidy, it's time to broaden your search. Independent pharmacies and specialty pharmacies are often your best bet for finding specialty medications like Tenofovir Alafenamide.
Here's why:
When you call, be specific: ask for "Vemlidy, tenofovir alafenamide 25 mg tablets" and whether they can order it if not currently in stock.
Pharmacy stock levels can vary throughout the week. Here are some timing strategies that can help:
If you've tried the steps above and still can't locate Tenofovir Alafenamide, here are additional options:
Your prescribing doctor — whether a hepatologist, gastroenterologist, or infectious disease specialist — likely has experience navigating these issues. Their office may have direct relationships with specialty pharmacies or can connect you with a patient navigator. Learn more about finding a doctor who prescribes Tenofovir Alafenamide.
Many insurance plans offer mail-order pharmacy options for specialty medications. Your medication is shipped directly to your home, often with a 90-day supply. This can be more reliable than retail pharmacy and sometimes cheaper too.
If there's a genuine supply issue and you cannot get Tenofovir Alafenamide, your doctor may temporarily switch you to an alternative like Entecavir (Baraclude) or Tenofovir Disoproxil Fumarate (Viread). Read our full guide on alternatives to Tenofovir Alafenamide.
Important: Never stop taking your hepatitis B medication without talking to your doctor first. Stopping suddenly can cause a severe flare-up of the virus, which can be dangerous.
Finding Tenofovir Alafenamide in stock takes a little extra effort, but the right tools make all the difference. Start with Medfinder for real-time pharmacy availability, reach out to independent and specialty pharmacies, and plan your refills ahead. With these strategies, you can keep your hepatitis B treatment on track without unnecessary gaps.
Your health is worth the extra phone call. Don't let a stocking issue become a treatment interruption.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.